drugset / Trial / NCT01959035
Aripiprazole Once-monthly in Patients With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
To obtain information on the safety, tolerability and effectiveness of aripiprazole once-monthly in a manner consistent with its intended use in everyday clinical practice in patients with schizophrenia who completed Study 14724A / NCT01795547.
Timeline
- Start
- 2013-10
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 300 mg | Intramuscular |
| Subject | Aripiprazole | Other / unclassified | 400 mg | Intramuscular |